Võrdle meetodeid

	Functional Assessment of Cancer Therapy-Breast (FACT-B)	Edmontoni sümptomite hindamise süsteem (ESAS)
Valdkond	Onkoloogiaõendus	Onkoloogiaõendus
Perekond	Process / pipeline	Process / pipeline
Tekkeaasta	1997	1991
Looja	Marilyn Brady and David Cella	Eduardo Bruera
Tüüp	Patient self-report disease-specific QoL instrument	Patient self-report multisymptom palliative care scale
Algallikas	Brady, M. J., Cella, D. F., Mo, F., et al. (1997). Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol, 15(3), 974–986.	Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991). The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care, 7(2), 6–9.
Rööpnimetused	FACT-B, FACT-Breast	ESAS, Edmonton Symptom Assessment Scale
Seotud	4	4
Kokkuvõte	The FACT-B is a comprehensive 36-item disease-specific quality-of-life instrument that integrates the generic FACT-G (27 items covering physical, social, emotional, and functional well-being) with a 9-item breast-cancer-specific subscale addressing body image, sexual function, arm symptoms, and treatment side effects. Developed by Brady et al. in 1997, the FACT-B is the gold-standard QoL measure for breast cancer research and clinical practice, used in hundreds of clinical trials and enabling comparison across breast cancer populations and treatment modalities.	The Edmonton Symptom Assessment System is a rapid, validated 9-item tool that assesses the severity of common symptoms in cancer and palliative care patients: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite loss, general well-being, and shortness of breath. Developed by Bruera and colleagues at the University of Alberta in 1991, the ESAS has become the standard symptom-screening instrument in oncology clinics, palliative care units, and end-of-life care settings worldwide, enabling efficient symptom prioritization and management escalation.